Cargando…
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer
BACKGROUND: To validate markers for cervical carcinoma (CC) and precancerous lesions related with HPV infections. METHODS: Three different cervical cancer cell lines C-33A, SiHa and Caski were used for secretome profiling by label-free quantitative proteomics. Cervical exfoliated cells and matching...
Autores principales: | Hao, Yi, Ye, Ming, Chen, Xiaona, Zhao, Hongli, Hasim, Ayshamgul, Guo, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893763/ https://www.ncbi.nlm.nih.gov/pubmed/33602229 http://dx.doi.org/10.1186/s12935-021-01802-5 |
Ejemplares similares
-
CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways
por: Chen, Xiaona, et al.
Publicado: (2021) -
Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients
por: Yang, Jiayue, et al.
Publicado: (2021) -
Clinical and Biological Significances of FBLN5 in Gastric Cancer
por: Bian, Xiulan, et al.
Publicado: (2023) -
Discovery and validation of novel biomarkers for detection of cervical cancer
por: Li, Zigang, et al.
Publicado: (2021) -
Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)